Marine omega-3 fatty acid (fish oil) supplementation has also been shown to reduce CRP in randomized trials among maintenance hemodialysis patients [18] and those with end-stage renal disease [19], and to reduce TNF-α and interleukin (IL)-6 among patients with diabetes [20] and chronic heart failure [21]. The gene discussed is TNF; the disease is diabetes mellitus.